The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) promises to address some of the residual shortcomings of existing metallic stents, such as late events induced by permanent caging of the coronary vessel. Scaffold restenosis (ScR) of BVS has been poorly described so far and treatment strategies for this event remain to be codified. We report on a case series of 14 lesions in 12 patients presenting with ScR and discuss their anatomical features and management strategies.
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry / Longo, G.; Granata, F.; Capodanno, D.; Ohno, Y.; Tamburino, C. I.; Capranzano, P.; La Manna, A.; Francaviglia, B.; Gargiulo, G.; Tamburino, C.. - In: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. - ISSN 1522-1946. - 85:7(2015), pp. 1150-1161. [10.1002/ccd.25819]
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry
Gargiulo G.;
2015
Abstract
The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) promises to address some of the residual shortcomings of existing metallic stents, such as late events induced by permanent caging of the coronary vessel. Scaffold restenosis (ScR) of BVS has been poorly described so far and treatment strategies for this event remain to be codified. We report on a case series of 14 lesions in 12 patients presenting with ScR and discuss their anatomical features and management strategies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
